Bioaffinity technologies announces notification of allowance for u.s. patent application for its diagnostic algorithm and test method for lung cancer

San antonio, texas--(business wire)-- #ai--the us patent and trademark office will issue biaf a new patent on its flow cytometry+ai platform that detects lung cancer as early as stage 1a.

BIAF Ratings Summary

BIAF Quant Ranking